Foley Equipped

SEC Creates New Cross-Border Task Force to Combat Fraud, Prioritizing Investigations of Foreign Issuers and Gatekeepers

On September 5, 2025, the U.S. Securities and Exchange Commission (SEC) announced the creation of the Cross-Border Task Force (“Task Force”) to identify and combat cross‑border fraud harming U.S. investors. The Task Force will primarily focus on investigating potential U.S. securities law violations related to foreign-based companies, such as market manipulation, and those gatekeepers, such as auditors and underwriters, which enable these companies to access U.S. capital markets.

SPAC 4.0: From Spectacular Failures to a Disciplined Renaissance

dark blue background with wavy diagonal lines

The Special Purpose Acquisition Company (SPAC) market has experienced one of the most dramatic arcs in modern financial history. From the euphoric boom of 2021 — when 613 SPACs raised $162 billion — to the crushing losses that left most de-SPAC companies trading far below their IPO price, the sector seemed destined to be remembered as a cautionary tale of speculative excess.

Foley Represents Summer Robotics in Series A Financing

Foley & Lardner LLP represented Summer Robotics, a pioneer in machine vision for vision-guided robotics, in its Series A financing. The round was led by Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc., with participation from Solasta Ventures, Naver, and other investors. Summer Robotics develops next-generation automation solutions powered by its Kortx […]

Foley Represents Prellis Biologics in Strategic Collaboration with Eli Lilly to Advance Human Antibody Therapeutics

Foley & Lardner LLP served as legal counsel to Prellis Biologics, Inc., a biotechnology company innovating human antibody discovery through organoid and artificial intelligence enabled technology, in its multi-target drug discovery and development collaboration with Eli Lilly and Company (Lilly). The strategic partnership combines Prellis’ first-of-a-kind biological AI with Lilly’s renowned research to accelerate the development of […]

Subscribe to our newsletter
Subscribe

© 2025 Foley & Lardner LLP
Attorney Advertisement
Images of people may not be Foley personnel.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome.